AFP5 天
PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance ...
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary ...
Mouse study finds impaired cell development: Intermittent fasting could be unsafe for teenagers
A recent study reveals that age plays a significant role in the outcomes of intermittent fasting. Researchers from Technical ...
Impacts5 天
PHC Partners with CCRM to Boost Cell Quality with Advanced T-Cell Expansion Solutions
PHC has partnered with CCRM to boost cell quality with advanced T-cell expansion solutions. Takeaway Points  PHC has ...
technologynetworks1 个月
T Cells’ Ability To Prevent Infections Opens New Avenues for Developing Vaccines
Historically, vaccine development has prioritised generating elevated levels of antibodies. This approach may not only limit the efficacy of vaccines but could also hinder our ability to combat ...
Cure Today1 天
Linvoseltamab BLA Resubmission Accepted by FDA for Review
The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...
来自MSN16 天
Leveragen and Moonlight Bio unite for T-cell therapy development
Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for challenging cancers. The partnership integrates Leveragen's Singularity Sapiens ...